A
Assembly Biosciences, Inc.
ASMB · NASDAQ · Healthcare · 653M
Closing price
$23.53
+3.11% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
-34.7×
Free cash flow yieldFCF yield
-15.6%
Return on equityROE
-3.0%
Operating margin
-16.8%
Net debt / EBITDAbalance-sheet strength
9.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.